In papillary thyroid carcinoma (PTC), a handful of KEAP1 alterations have been identified and associated with increased nuclear NRF2 expression, correlating the mutations with NRF2 stabilization (45). This evidence concerns the gene NFE2L2 and thyroid gland papillary carcinoma.